Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
13
×
boston blog main
boston top stories
biotech
new york blog main
new york top stories
san francisco blog main
san francisco top stories
gene therapy
clinical trials
deals
national
hemophilia
indiana blog main
indiana top stories
novartis
san diego blog main
san diego top stories
spark therapeutics
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
raleigh-durham blog main
raleigh-durham top stories
roche
san francisco
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
zolgensma
alnylam pharmaceuticals
boston
cancer
What
therapy
13
×
gene
drug
fda
approval
bio
medicine
patients
roundup
therapeutics
advanced
approved
aren’t
car
cutting
deal
edge
friday
help
long
market
medicines
moves
oral
past
race
rna
roche
science
treat
won
access
address
age
agency
aimmune
allergy
alnylam’s
approves
atrophy
Language
unset
Current search:
therapy
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”